Ethiopia has confirmed a deadly outbreak of Marburg virus in southern Ethiopia, bringing concerns for global health. According to Africa CDC, at least nine cases have been detected in the Jinka area, with a fatality rate estimated between 25% and 80%. The Marburg virus, similar to Ebola, causes severe bleeding, fever, vomiting, and diarrhea.
The World Health Organization confirmed the outbreak, stating that further epidemiological investigations are underway. Africa CDC expressed concern over the spread of the virus in east Africa, stating it would work closely with Ethiopian authorities to contain the outbreak.
This is not the first reported case of Marburg virus; an epidemic in Tanzania killed 10 people in January before being terminated in March. Rwanda also managed to stamp out its first known Marburg epidemic, causing 15 deaths in December last year.
Currently, there is no approved vaccine or antiviral treatment for the Marburg virus. However, oral rehydration and symptom treatment have been shown to increase patients' chances of survival. In a trial conducted by Rwanda's health authorities, an experimental vaccine from the US-based Sabin Vaccine Institute showed promise in preventing the spread of the virus.
Health experts are urged to exercise caution as this is not a disease easily contained.
The World Health Organization confirmed the outbreak, stating that further epidemiological investigations are underway. Africa CDC expressed concern over the spread of the virus in east Africa, stating it would work closely with Ethiopian authorities to contain the outbreak.
This is not the first reported case of Marburg virus; an epidemic in Tanzania killed 10 people in January before being terminated in March. Rwanda also managed to stamp out its first known Marburg epidemic, causing 15 deaths in December last year.
Currently, there is no approved vaccine or antiviral treatment for the Marburg virus. However, oral rehydration and symptom treatment have been shown to increase patients' chances of survival. In a trial conducted by Rwanda's health authorities, an experimental vaccine from the US-based Sabin Vaccine Institute showed promise in preventing the spread of the virus.
Health experts are urged to exercise caution as this is not a disease easily contained.